Pharming Group N.V. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was EUR 185.694 million compared to EUR 169.022 million a year ago. Operating income was EUR 67.421 million compared to EUR 60.907 million a year ago. Net income was EUR 32.654 million compared to EUR 36.195 million a year ago. Basic earnings per share from continuing operations was EUR 0.051 compared to EUR 0.058 a year ago. Diluted earnings per share from continuing operations was EUR 0.048 compared to EUR 0.054 a year ago.